Αρχειοθήκη ιστολογίου

Αναζήτηση αυτού του ιστολογίου

Τετάρτη 4 Ιουλίου 2018

The influence of obstacles on grasp planning

Abstract

When reaching to grasp for an object in the absence of obstacles, the choice of contact points is highly consistent within and between healthy humans, suggesting a preplanning of grasping movements (Gilster et al. in Exp Brain Res 217:137–151, 2012). In real life, objects may obstruct the favored contact points at a target object, requiring adjustments to avoid collision. In the present study, we investigated how an obstacle that directly obstructs the favored contact points for two-digit grasping changes the planning and execution of reach-to-grasp movements. Furthermore, we elucidated to what extent an obstacle placed at various angular positions around the target object (thereby not directly obstructing the favored contact points) still influences trajectories, contact points, and time-related parameters. When obstacles directly obstructed favored contact points participants either chose a completely new contact point or grasped the object only slightly away from the favored contact point. Obstacles located near the favored contact points but not directly obstructing them still resulted in a repulsive effect, meaning that contact points were shifted away from the obstacle to ensure sufficient distance to the obstacle. We found that the position of an obstacle even influences the direction in which the fingers set off. This leads to a deviation of the trajectory very early in the time course, yielding longer movement times if the main contact points are obstructed. Taken together, the early significant influence of obstacles on the grasping movement supports the assumption that grasping movements are preplanned.



https://ift.tt/2KGSx8u

Discriminating radiation injury from recurrent tumor with [ 18 F]PARPi and amino acid PET in mouse models

Abstract

Background

Radiation injury can be indistinguishable from recurrent tumor on standard imaging. Current protocols for this differential diagnosis require one or more follow-up imaging studies, long dynamic acquisitions, or complex image post-processing; despite much research, the inability to confidently distinguish between these two entities continues to pose a significant dilemma for the treating clinician. Using mouse models of both glioblastoma and radiation necrosis, we tested the potential of poly(ADP-ribose) polymerase (PARP)-targeted PET imaging with [18F]PARPi to better discriminate radiation injury from tumor.

Results

In mice with experimental radiation necrosis, lesion uptake on [18F]PARPi-PET was similar to contralateral uptake (1.02 ± 0.26 lesion/contralateral %IA/ccmax ratio), while [18F]FET-PET clearly delineated the contrast-enhancing region on MR (2.12 ± 0.16 lesion/contralateral %IA/ccmax ratio). In mice with focal intracranial U251 xenografts, tumor visualization on PARPi-PET was superior to FET-PET, and lesion-to-contralateral activity ratios (max/max, p = 0.034) were higher on PARPi-PET than on FET-PET.

Conclusions

A murine model of radiation necrosis does not demonstrate [18F]PARPi avidity, and [18F]PARPi-PET is better than [18F]FET-PET in distinguishing radiation injury from brain tumor. [18F]PARPi-PET can be used for discrimination between recurrent tumor and radiation injury within a single, static imaging session, which may be of value to resolve a common dilemma in neuro-oncology.



https://ift.tt/2Nq9F0X

Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT

Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT

Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT, Published online: 03 July 2018; doi:10.1038/s41419-018-0774-8

Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT

https://ift.tt/2IOjh1T

Can we conclude a potential therapeutic action for Parkinson’s disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin?

Can we conclude a potential therapeutic action for Parkinson's disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin?

Can we conclude a potential therapeutic action for Parkinson's disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin?, Published online: 03 July 2018; doi:10.1038/s41419-018-0798-0

Can we conclude a potential therapeutic action for Parkinson's disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin?

https://ift.tt/2tQkOQu

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer, Published online: 03 July 2018; doi:10.1038/s41419-018-0776-6

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

https://ift.tt/2KIwOd0

Thin is required for cell death in the Drosophila abdominal muscles by targeting DIAP1

Thin is required for cell death in the Drosophila abdominal muscles by targeting DIAP1

Thin is required for cell death in the <i>Drosophila</i> abdominal muscles by targeting DIAP1, Published online: 03 July 2018; doi:10.1038/s41419-018-0756-x

Thin is required for cell death in the Drosophila abdominal muscles by targeting DIAP1

https://ift.tt/2NpuIAI

FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer

FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer

FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer, Published online: 03 July 2018; doi:10.1038/s41419-018-0790-8

FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer

https://ift.tt/2IOjdzb